C7 lactyloxy-substituted taxanes

Details C7 lactyloxy-substituted taxanes C7 lactyloxy-substituted taxanes

2007-01-09

2007-01-09

McKenzie, Thomas (Department: 1625)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C549S510000

Reexamination Certificate

active

11071912

ABSTRACT:
A taxane having the formula:wherein X3is furyl, X5is t-butoxycarbonyl, Bz is benzoyl, and Ac is acetyl.

REFERENCES:
patent: 4960790 (1990-10-01), Stella et al.
patent: 5175315 (1992-12-01), Holton
patent: 5200534 (1993-04-01), Rao
patent: 5227400 (1993-07-01), Holton et al.
patent: 5243045 (1993-09-01), Holton et al.
patent: 5248796 (1993-09-01), Chen et al.
patent: 5283253 (1994-02-01), Holton et al.
patent: 5319112 (1994-06-01), Kingston et al.
patent: 5350866 (1994-09-01), Holton et al.
patent: 5352806 (1994-10-01), Gunawardana et al.
patent: 5415869 (1995-05-01), Straubinger et al.
patent: 5422364 (1995-06-01), Nicolaou et al.
patent: 5430160 (1995-07-01), Holton
patent: 5489601 (1996-02-01), Holton et al.
patent: 5530020 (1996-06-01), Gunawardana et al.
patent: 5567614 (1996-10-01), Patel et al.
patent: 5614645 (1997-03-01), Kingston et al.
patent: 5714513 (1998-02-01), Holton et al.
patent: 5721268 (1998-02-01), Holton et al.
patent: 5767297 (1998-06-01), Mandai et al.
patent: 5780653 (1998-07-01), Tao et al.
patent: 5811452 (1998-09-01), Ojima et al.
patent: 5879929 (1999-03-01), Patel
patent: 5912264 (1999-06-01), Wittman et al.
patent: 5965739 (1999-10-01), Kelly et al.
patent: 6136988 (2000-10-01), Murray et al.
patent: 6160135 (2000-12-01), Bouchard et al.
patent: 6576636 (2003-06-01), Webb et al.
patent: 6673833 (2004-01-01), Holton
patent: 0 558 959 (1993-09-01), None
patent: 0 590 267 (1994-04-01), None
patent: 0 629 701 (1994-12-01), None
patent: 0 747 385 (1996-12-01), None
patent: WO 90/10443 (1990-09-01), None
patent: WO 93/02065 (1993-02-01), None
patent: WO 94/14787 (1994-07-01), None
patent: 94/21250 (1994-09-01), None
patent: WO 95/11241 (1995-04-01), None
patent: WO 95/13053 (1995-05-01), None
patent: WO 97/09979 (1997-03-01), None
patent: WO 97/42181 (1997-11-01), None
patent: WO 97/44026 (1997-11-01), None
patent: WO 97/44063 (1997-11-01), None
patent: WO 99/09021 (1999-02-01), None
patent: WO 00/01366 (2000-01-01), None
patent: WO 00/78707 (2000-12-01), None
patent: WO 01/25223 (2001-04-01), None
patent: WO 01/57013 (2001-08-01), None
patent: WO 01/57027 (2001-08-01), None
patent: WO 01/68089 (2001-09-01), None
Safarpour, H., et al., “Concentration of Milataxel (MAC-321, TL00139) and its Major Metabolite (M-10) in Xenograft Tumors from Mice Dosed Orally and Intravenously,” Abstract #512, 97th Annual Meeting of the American Association for Cancer Research, Apr. 1-5, 2006, Washington, D.C.
Yang, Li-Xi, et al., “Enhanced Apoptotic Effects of Novel Paclitaxel Analogs on NCI/ADR-RES Breast Cancer Cells,” AntiCancer Research 23:3295-3302 (2003), San Francisco, California.
Sampath, D., et al., “MAC-321, A Novel Taxane With Greater Efficacy Than Paclitaxel and Docetaxel In Vitro and In Vivo,” Molecular Cancer Therapeutics, 2003, pp. 873-884.
International Search Report, PCT/US05/07100, from the International Searching Authority dated Jun. 21, 2005.
Deutsch, H.M., et al., “Synthesis of Congeners and Prodrugs. 3. Water-Soluble Prodrugs of Taxol with Potent Antitumor Activity,”Journal of Medicinal Chemistry, 1989, pp. 788-792, vol. 32, No. 4.
Dubois, J., “Fluorescent and Biotinylated Analogues of Docetaxel: Synthesis and Biological Evaluation,”Bioorganic&Medicinal Chemistry, 1995, pp. 1357-1368, vol. 3, No. 10.
European Search Report for EP 01 11 8729 dated Oct. 30, 2001.
Ferlini, C., et al., “Antitumor Activity of Novel Taxanes that Act at the Same Time as Cytotoxic Agents and P-Glycoprotein Inhibitors,”British Journal of Cancer, 2000, pp. 1762-1768, vol. 83, No. 12.
Guenard, D., et al., “Effects of the Hydrophobicity of Taxoids on their Interaction with Tubulin,”Bioorganic&Medicinal Chemistry, 2000, pp. 145-156, vol. 8.
Gueritte-Voégelein, F., et al., “Relationships Between the Structure of Taxol Analogues and Their Antimitotic Activity,”Journal of Medicinal Chemistry, 1991, pp. 992-998, vol. 34, No. 3.
Hungarian Search Report from Application No. P0103247 dated Dec. 14, 2004.
International Search Report from PCT Application No. PCT/US01/03385 dated Jun. 11, 2001.
Ishihara, K., et al., “Scandium Trifluoromethanesulfonate as an Extremely Active Acylation Catalyst,”Journal of the American Chemical Society, 1995, pp. 4413-4414, vol. 117, No. 15.
Kingston, D.G.I., et al., “The Chemistry of Taxol, A Clinically Useful Anticancer Agent,”Journal of Natural Products, Jan.-Feb. 1990, pp. 1-12, vol. 53, No. 1.
Klein, L.L., “Synthesis of 9-Dihydrotaxol: A Novel Bioactive Taxane,”Tetrahedron Letters, 1993, pp. 2047-2050, vol. 34, No. 13, Pergamon Press, Ltd.
Liang, X., et al., “Synthesis and Biological Evaluation of Paclitaxel Analogs Modified in Ring C,”Tetrahedron Letters, 1995, pp. 2901-2904, vol. 36, No. 17, Pergamon Press, Ltd.
Mellado, W., et al., “Preparation and Biological Activity of Taxol Acetates,”Biochemical and Biophysical Research Communications, Oct. 30, 1984, pp. 329-336, vol. 124, No. 2.
Ojima, I., et al., “New Photoaffinity Analogs of Paclitaxel,”Bioorganic&Medicinal Chemistry Letters, 1999, pp. 1189-1194, vol. 9.
Patel, R.N., “Tour de Paclitaxel: Biocatalysis for Semisynthesis,”Annual Review of Microbiology, 1998, pp. 361-395, vol. 52.
Shi, B.X., et al., “Studies on the Quantitative Structure-activity Relationships of Paclitaxel Analogues,”Chemical Journal of Chinese Universities, 2000, pp. 401-406. vol. 21, No. 3.
Straubinger, R.M., et al., “Pharmacology and Antitumor Effect of Novel Paclitaxel Formulations,” Chapter 8, ACS Symposium Series 583, 207th National Meeting of the American Chemical Society, 1994, pp. 111-123.
Suffness, M., “Chapter 32. Taxol: From Discovery to Therapeutic Use,” Annual Reports in Medicinal Chemistry, 1993, pp. 305-314, vol. 28.
Vyas, D.M., et al., “Phosphatase-Activated Prodrugs of Paclitaxel,” Chapter 9, ACS Symposium Series 583, 207th National Meeting of the American Chemical Society, 1994, pp. 124-137.

Affiliated with

Also associated with

Rating

C7 lactyloxy-substituted taxanes does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with C7 lactyloxy-substituted taxanes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and C7 lactyloxy-substituted taxanes will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3801556